|
Federal
Register Notices > Notices
of Registration - 2003 > Lipomed, Inc
[Federal Register: June 17, 2003 (Volume 68,
Number 116)]
[Notices]
[Page 35917-35918]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17jn03-90]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of
Registration
By notice dated January 27, 2003, and published in
the Federal Register on February 6, 2003 (68 FR 6183), Lipomed, Inc.,
One Broadway, Cambridge, Massachusetts 02142, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered as
an importer of the basic class of controlled substances listed below:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methaqualone (2565) |
I |
| Lysergic acide diethylamide
(7315) |
I |
| Marihuana (7360) |
I |
| Tetrahydrocannabinols (7307) |
I |
| Mescaline (7381) |
I |
| 3,4,5-Trimethoxyamphetamine
(7391) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine
(7391) |
I |
| 4-Methyl-2,5-dimethoxyamphetamine
(7395) |
I |
[[Page 35918]]
| Drug |
Schedule |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,5-Dimethoxy-4-ethylamphetamine
(7399) |
I |
| 3,4-Methylenedioxyamphetamine
(7400) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine
(7404) |
I |
| 3,4-Methylenedioxymethamphetamine
(7405) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| Acetyldihydrocodeine (9051) |
I |
| Dihydromorphine (9145) |
I |
| Heroin (9200) |
I |
| Tilidine (9750) |
I |
| Amphetamie (1100) |
II |
| Methamphetamine (1105) |
II |
| Amobarbital (2125) |
II |
| Secobarbital (2315) |
II |
| Phencyclidine (7471) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Benzoylecgonine (9180) |
II |
| Hydrocodone (9193) |
II |
| Levorphanol (9220) |
II |
| Methadone (9250) |
II |
| Dextrophrpoxyphene, bulk
(non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Oxymorphone (9652) |
II |
| Alfentanil (9737) |
II |
| Fentanyl (9801) |
II |
The firm plans to import small reference standard
quantities of finished commercial product from its sister company in
Switzerland for sale to its customers for drug testing.
No comments or objections have been received. DEA
has considered the factors in title 21, United States Code, section
823(a) and determined that the registration of Lipomed, Inc. to import
the listed controlled substances is consistent with the public interest
and with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA
has investigated Lipomed, Inc. on a regular basis to ensure that the
company's continued registration is consistent with the public interest.
This investigation included inspection and testing of the company's
physical security systems, verification of the company's compliance with
state and local laws, and a review of the company's background and
history. Therefore, pursuant to section 1008(a) of the Controlled
Substances Import and Export Act and in accordance with title 21, Code
of Federal Regulations, section 1301.34, the above firm is granted
registration as an importer of the basic classes of controlled
substances listed above.
Dated: June 6, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-15200 Filed 6-16-03; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
